semaglutide early pregnancy Obstetrics & Gynecology | “With rising obesity rates and increasing glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, understanding perinatal prescribing Impact of semaglutide exposure on

GLP-1 receptors are distributed throughout multiple organ systems beyond the pancreas, including the cardiovascular system and kidneys

10.1017/S0007114513000548 Br J Nutr

House of Representatives could nudge CMS to cover it more broadly for people with obesity alone

But heres where it gets interesting, most of the weight loss occurs at higher doses than this so a lot of people using Ozempic will be unlikely to get the dramatic results people are talking about on social media

Advance equitable access and shape policy : GLP-1 medications have the potential to significantly benefit populations with lower socioeconomic status, yet these groups often face the greatest barriers to access